Conference
A phase I study of a second generation antisense oligonucleotide to clusterin (OGX-011) in combination with docetaxel: NCICCTG IND. 154.
Authors
Chi KN; Eisenhauer E; Siu L; Hirte H; Hotte SJ; Chia S; Knox J; Guns E; Powers J; Gleave ME
Volume
23
Pagination
pp. 213S-213S
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 1, 2005
Name of conference
41st Annual Meeting of the American-Society-of-Clinical-Oncology
Conference place
Orlando, FL
Conference start date
May 13, 2005
Conference end date
May 17, 2005
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
16
ISSN
0732-183X